ID: eucommia_ulmoides_leaf_extract
Aliases: duzhong leaf extract, Eucommia leaf extract
Type: botanical_extract
Route/form: oral supplement/extract unless otherwise specified
Status: supplement_or_research
Evidence level: preclinical
Best data tier: non-human experimental
Support scope: non-human/mechanistic, review/regulatory
Source types: preclinical, review
Linked sources: 2
Broad outcomes: Cardiovascular / lipids / blood pressure, Hormones / fertility / sexual health
Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.
Targets / mechanism
- Akt-eNOS pathway
- nitric oxide production
- oxidative stress
- HPG-axis markers
Optimization domains
- erectile quality
- cardiovascular health
- endothelial function
- botanical
Research basis
- A diabetic-rat erectile-dysfunction model reports improved erectile function, oxidative stress markers, NO production, Akt-eNOS activation, and HPG-axis markers.
- Useful as a vascular/endocrine botanical ED lead.
Limits, risks, and missing evidence
- Diabetic-rat ED findings do not establish human erectile benefit.
- HPG-axis marker changes should not be generalized to hormone optimization in healthy humans.
Risk flags
- preclinical only
- limited human data
- botanical identity
- endocrine claim caution
Linked papers, labels, and reviews
- Eucommia ulmoides leaf extract improves erectile dysfunction in diabetic rats
preclinical / pmc_eucommia_ed_2019
STZ diabetic rat erectile function, Akt-eNOS, NO, oxidative stress, and HPG-axis source. - Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.
review / biomedcentral_eucommia_review_2021
Broad Eucommia ulmoides pharmacology review that discusses erectile, metabolic, cardiovascular, and traditional-use claims.